Novo Nordisk CSO Says R&D Revamp Reflects New Stem Cell And AI Focus

 
• By Sten Stovall
  
Novo Nordisk
Stem Cell-based Therapies To Be New Focus At Novo Nordisk • Source: Shutterstock

More from Strategy

More from Business